Published guidance, NICE advice and quality standards | Guidance

Showing 631 to 640 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia	TA343	2 June 2015	2 June 2015
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome	TA335	25 March 2015	25 March 2015
Empagliflozin in combination therapy for treating type 2 diabetes	TA336	25 March 2015	25 March 2015
Rifaximin for preventing episodes of overt hepatic encephalopathy	TA337	25 March 2015	25 March 2015
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	25 February 2015	25 February 2015
Sofosbuvir for treating chronic hepatitis C	TA330	25 February 2015	25 February 2015
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment	TA333	25 February 2015	25 February 2015
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)	TA334	25 February 2015	25 February 2015
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma	TA269	12 December 2012	1 January 2015
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism	TA327	17 December 2014	17 December 2014